Venture_Socks_RZ_RGB_300dpi(2)_edited.pn

NETWORK

Fabian Buller

Chief Business Officer at Neurimmune AG

Health & Nutrition

Chief Business Officer at Neurimmune AG

Neurimmune is a Swiss clinical stage biotech company translating human immune memory into next generation antibody therapeutics. Fabian Buller is an experienced biotech executive with 8 years of professional experience in biotech and pharma. Prior to his position at Neurimmune, Fabian Buller served as Director New Ventures at Johnson & Johnson Innovation as well as Director Business Development of Covagen AG. He was instrumental in securing a number of major Biotech-Pharma deals including the sale of Covagen to J&J. Fabian Buller, a chemist by training, holds a PhD degree from the Institute of Chemistry and Applied Biosciences at ETH Zurich.

Venture_GreenLayer_v2_edited.png